|1.||Kubera, Marta: 5 articles (03/2014 - 11/2009)|
|2.||Jan, Chung-Ren: 4 articles (03/2009 - 12/2003)|
|3.||Oliveto, Alison: 4 articles (01/2005 - 01/2002)|
|4.||Popoli, Maurizio: 3 articles (02/2015 - 03/2003)|
|5.||Wrona, Danuta: 3 articles (03/2014 - 12/2011)|
|6.||Qi, Hong: 3 articles (02/2013 - 09/2002)|
|7.||Chen, Hong-Zhuan: 3 articles (02/2013 - 09/2002)|
|8.||Basta-Kaim, Agnieszka: 3 articles (01/2013 - 11/2009)|
|9.||Grygier, Beata: 3 articles (01/2013 - 11/2009)|
|10.||Budziszewska, Bogusława: 3 articles (01/2013 - 11/2009)|
01/01/2014 - "No pooling of data was possible, but third tier evidence in individual studies indicated some improvement in pain relief with desipramine compared with placebo, although this was very low quality evidence, derived mainly from group mean data and completer analyses in small, short duration studies where major bias was possible. "
01/01/2014 - "There may be a role for desipramine in patients who have not obtained pain relief from other treatments."
03/01/1990 - "Pain relief with desipramine was statistically significant from weeks 3 to 6. Psychiatric interview at entry into the study produced a diagnosis of depression for 4 patients; pain relief was similar in depressed and nondepressed patients and was statistically significant in the nondepressed group alone. "
03/01/1990 - "Desipramine has the least anticholinergic and sedative effects of the first generation tricyclic antidepressant agents, but its pain-relieving potential has received little study. "
01/01/2013 - "Patients were stratified into two subgroups based upon treatment with desipramine for OAB alone (n = 29) or OAB and bladder pain (n = 14). "
|2.||Neuralgia (Stump Neuralgia)
01/01/2014 - "To assess the analgesic efficacy of desipramine for chronic neuropathic pain in adults, and to assess the associated adverse events. "
01/01/2014 - "This review found little evidence to support the use of desipramine to treat neuropathic pain. "
01/01/2014 - "We included randomised, double-blind studies of at least two weeks duration comparing desipramine with placebo or another active treatment in chronic neuropathic pain. "
01/01/2014 - "Desipramine for neuropathic pain in adults."
02/01/2009 - "Identification of discrete sites of action of chronic treatment with desipramine in a model of neuropathic pain."
|3.||Panic Disorder (Panic Attack)
12/01/1985 - "Independent of DSM-III diagnosis, however, evidence of panic attacks seemed to identify patients who benefited from desipramine therapy. "
01/01/1987 - "Preliminary results of an open, fixed-dose study of desipramine in panic disorder."
03/01/1995 - "Desipramine plasma levels and treatment response in panic disorder."
01/01/1993 - "Preliminary report: placebo-controlled, double-blind study of the clinical and metabolic effects of desipramine in panic disorder."
04/01/1991 - "Desipramine treatment in panic disorder."
|4.||Cocaine-Related Disorders (Cocaine Addiction)
01/01/1984 - "Desipramine was compared with a placebo under double-blind conditions to determine if it is effective treatment for withdrawal from cocaine dependence. "
03/01/2003 - "This finding supports previous reports of a possible role for desipramine in cocaine abuse treatment."
09/01/2000 - "Conversely, uptake inhibitors, such as the tricyclic antidepressant, desipramine, and the drug of abuse, cocaine, inhibit noradrenergic differentiation in both tissues. "
03/01/1994 - "Desipramine treatment for cocaine dependence. "
10/01/1992 - "Research on desipramine in the treatment of cocaine abuse: a critique of Levin and Lehman's meta-analysis."
01/01/2011 - "Although there is evidence that desipramine is effective for both tics and ADHD in children, safety concerns will likely continue to limit its use in this population. "
07/01/2002 - "The tic response rate was substantial (58% vs 5%; desipramine vs placebo, P<.001). "
07/01/2002 - "Likewise, desipramine significantly reduced tic symptoms (Yale Global Tic Severity Scale; 30% decrease from baseline relative to placebo, P<.001), with equal response in motor and phonic tic symptoms (P<.01 for both). "
01/01/1995 - "Desipramine showed a statistically significant improvement on a global linear analogue scale, but not on the Hopkins Motor/Vocal Tic Severity Scale, the Tourette Syndrome Severity Scale, or the Yale Global Tic Severity Scale. "
07/01/2002 - "Treatment with desipramine was well tolerated and was associated with robust clinically significant reductions in tic and ADHD symptoms in children and adolescents with chronic tic disorders and ADHD diagnoses."
|2.||Tricyclic Antidepressive Agents (Tricyclic Antidepressants)
|6.||Serotonin (5 Hydroxytryptamine)
|8.||Antidepressive Agents (Antidepressants)
|10.||Cocaine (Cocaine HCl)